Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-07-001153
Filing Date
2007-03-16
Accepted
2007-03-16 16:13:01
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w31999e10vk.htm 10-K 1221571
2 EXHIBIT 10.19 w31999exv10w19.htm EX-10.19 78558
3 EXHIBIT 23.1 w31999exv23w1.htm EX-23.1 1225
4 EXHIBIT 31.1 w31999exv31w1.htm EX-31.1 8659
5 EXHIBIT 31.2 w31999exv31w2.htm EX-31.2 8283
6 EXHIBIT 32.1 w31999exv32w1.htm EX-32.1 6246
7 GRAPHIC w31999w3199902.gif GRAPHIC 9156
  Complete submission text file 0000950133-07-001153.txt   1338754
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51863 | Film No.: 07700309
SIC: 2834 Pharmaceutical Preparations